Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Japanese MHLW approves Novo Nordisk's combination therapy for diabetes

Dec. 28, 2012

Otsuka obtains new approvals for carnitine deficiency treatments

Dec. 28, 2012

Japanese researchers patent new insulin secretagogues

Dec. 28, 2012

Takeda and Amylin terminate worldwide agreement

Dec. 28, 2012

Once-monthly formulation of antiosteoporotic agent approved in Japan

Dec. 27, 2012

FDA approves Juxtapid for homozygous familial hypercholesterolemia

Dec. 27, 2012

Raptor Pharmaceutical provides update on NDA review for Procysbi

Dec. 27, 2012

Ranbaxy Laboratories presents new DPP IV inhibitor for the treatment of diabetes

Dec. 27, 2012

Novel agents for obesity disclosed by GlaxoSmithKline

Dec. 27, 2012

Catabasis Pharmaceuticals presents new GABA conjugates

Dec. 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...